Skip to main content
Abrdn PLC logo

Abrdn PLC — Investor Relations & Filings

Ticker · ABDN ISIN · GB00BF8Q6K64 LEI · 0TMBS544NMO7GLCE7H90 IL Financial and insurance activities
Open in API
Filings indexed 4,552 across all filing types
Latest filing 2023-07-18 Regulatory Filings
Country GB United Kingdom
Listing IL ABDN

About Abrdn PLC

https://www.abrdn.com/en-gb

Abrdn PLC is a global investment company and asset manager formed from the 2017 merger of Standard Life and Aberdeen Asset Management. The firm offers a range of investment solutions, funds, and investment trusts. It serves a diverse client base that includes individual customers, financial advisers, wealth managers, and institutional investors. The company focuses on providing expertise and tools to help clients manage and grow their wealth, enabling them to prepare for their financial future.

Recent filings

Filing Released Lang Actions
Form 8.3 - Gresham House plc (OPD)
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code (the "Code")'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offer involving 'Gresham House plc'. This type of mandatory disclosure related to takeover activity and insider/significant shareholder dealings is a specific regulatory filing. While it relates to director/insider activity (which might suggest DIRS), the context of the Takeover Code (Rule 8.3) and the structure of the disclosure (position disclosure during an offer period) makes it a specialized regulatory announcement. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing distributed via RNS, the most appropriate classification is the general 'Regulatory Filings' (RNS), as it is not a standard 10-K, ER, or DIRS filing, but a specific market disclosure required by the Takeover Panel.
2023-07-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from abrdn PLC dated July 18, 2023. The title is explicitly 'Transactions in own shares'. The content details the purchase of ordinary shares on the London Stock Exchange on July 17, 2023, including volume, price, and individual transaction logs. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2023-07-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title: "Transactions in own shares". It details the purchase of ordinary shares by abrdn plc on the London Stock Exchange on 14 July 2023, including volume, highest/lowest/VWAP prices, and a table of individual transactions. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The RNS Number suggests it is a regulatory announcement, but the content is specific to share repurchase activity, making POS the most accurate classification over the general RNS fallback.
2023-07-17 English
Form 8.3 - Dechra Pharmaceuticals PLC
Major Shareholding Notification Classification · 97% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' in the context of a takeover offer (specifically mentioning Dechra Pharmaceuticals PLC as the offeree). This type of filing relates to insider dealing or significant shareholder activity during a takeover scenario. While it involves director/insider activity (similar to DIRS), the specific context of the Takeover Code disclosure (Form 8.3) dealing with interests in an offeror/offeree is a specialized regulatory filing. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate classification is the general regulatory filing category, RNS, as it is not a standard Director's Dealing report (DIRS) which usually refers to Form 3/4 filings under SEC rules, nor is it a general M&A announcement (TAR). Given the structure and source (RNS Number), RNS is the best fit among the provided options for a specific, non-standard regulatory disclosure.
2023-07-14 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from abrdn PLC dated 14 July 2023. The title is "Transactions in own shares" and the content details the purchase of ordinary shares on the London Stock Exchange on 13 July 2023, including volume, price, and individual transaction logs. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate filing type code is POS.
2023-07-14 English
Form 8.3 - Dechra Pharmaceuticals PLC
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' in the context of a takeover offer (specifically mentioning 'Dechra Pharmaceuticals PLC' as the offeree). This type of mandatory disclosure related to insider/significant shareholder activity during a takeover bid is a specific regulatory filing. While it relates to director/insider dealings (DIRS), the specific context of a takeover disclosure (Form 8.3) makes it a specialized regulatory announcement. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate classification is the general 'Regulatory Filings' (RNS), as it is not a standard DIRS filing (which usually refers to Form 3, 4, or 5 under SEC rules, or similar general insider transaction reports, not takeover code disclosures). However, given the detailed nature of the definitions, and the fact that it reports dealings by a director/insider (abrdn plc) in relation to an offer, it is a highly specific regulatory filing. Since 'DIRS' is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is an insider transaction report related to a takeover, DIRS is a strong candidate. However, Form 8.3 is specifically about interests in an offer. Given the options, and the fact that it is a mandatory disclosure to the Takeover Panel via RNS, RNS is the safest general regulatory bucket, but DIRS captures the essence of the content (insider dealing/interest). Let's re-evaluate: DIRS is for general insider trades. This is a specific takeover-related disclosure. RNS is the fallback for miscellaneous regulatory filings. Since this is a specific regulatory form (Form 8.3) related to a takeover, and not a general earnings report or annual filing, RNS is the best fit among the provided options for a non-standard regulatory document.
2023-07-13 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.